| Dr Anita Roshini Banerjee, PHARMD | |
|
1096 Highway 33, Trenton, NJ 08690-2710 | |
| (609) 689-3060 | |
| Not Available |
| Full Name | Dr Anita Roshini Banerjee |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1096 Highway 33, Trenton, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013384445 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 28RI03712600 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anita Roshini Banerjee, PHARMD 1096 Nj-33, Hamilton, NJ 08690 Ph: (609) 689-3060 | Dr Anita Roshini Banerjee, PHARMD 1096 Highway 33, Trenton, NJ 08690-2710 Ph: (609) 689-3060 |
News Archive
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today launched the next generation of its Perceptive MyTrials platform with advanced analytics capabilities. With the Perceptive MyTrials Analytics solution, clinical trial sponsors can now use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously.
Avanir Pharmaceuticals, Inc. today announced that it has entered into a definitive agreement with Otsuka Pharmaceutical Co., Ltd. pursuant to which Otsuka will acquire Avanir for $17.00 per share in cash.
Type 1 diabetes is a chronic condition in which the body's own immune system attacks and destroys beta cells in the pancreas. Once the beta cells are destroyed, the pancreas can no longer produce insulin. Currently, there is no cure for T1D and treatment focuses on managing blood sugar levels.
A detailed analysis of the epigenetics - factors controlling when and in what tissues genes are expressed - of Wilms tumor reveals striking similarities to stem cells normally found in fetal kidneys. These findings by Massachusetts General Hospital Cancer Center researchers have revealed new cellular pathways that are critical for Wilms tumor development and may also apply to other pediatric cancers.
An examination of the reporting of noninferiority clinical trials raises questions about the adequacy of their registration and results reporting within publicly accessible trial registries, according to a study in the March 17 issue of JAMA.
› Verified 9 days ago
Mr. Gerald B Charney, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 Kuser Rd, Trenton, NJ 08690 Phone: 609-585-3925 Fax: 609-585-8753 | |
John Edward Berkenkopf, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1125 Chambers St, Trenton, NJ 08610 Phone: 609-393-3017 Fax: 609-396-3459 | |
Janet D Fleming, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2645 S Broad St, Trenton, NJ 08610 Phone: 609-888-2203 | |
Rachel Addy, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1096 Route 33, Trenton, NJ 08690 Phone: 609-689-3060 | |
Dr. Aneesha Bhatia, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6000 | |
Farah Ahmed, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 609-394-6000 |